share_log

西点药业(301130.SZ)主要股东国投高科及其一致行动人累计减持比例达1.03%

The major shareholders of Xidian Pharmaceutical (301130.SZ), Guotou Gaoke and its concerted actors, have cumulatively reduced their shareholding by 1.03%.

Zhitong Finance ·  Dec 2 16:24

West Pharma (301130.SZ) announced that the company's shareholder, Guotou High Technology Investment Co., Ltd. (referred to as 'Guotou High-Tech'), holding more than 5% of the shares, plans to reduce its shareholding...

According to the announcement from West Pharma (301130.SZ) on Zhitong Finance APP, the company's shareholder, Guotou High Technology Investment Co., Ltd. (referred to as 'Guotou High-Tech'), and its concerted actor Hangzhou Chuanghe Selected Entrepreneurial Investment Partnership (Limited Partnership) (referred to as 'Hangzhou Chuanghe'), will collectively reduce their company's shares by 0.7865 million shares through centralized bidding and block trades from November 19, 2024, to November 29, 2024. The total reduction of shares accounts for 1.03% of the company's total share capital (excluding repurchases).

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment